Background: The efficacy and applicability of molecular testing to guide the selection of antibiotics in triple ( eradication regimens have not been reported. We tested a 7-day, genotypic resistance-guided triple eradication therapy in a high-resistance setting.
Methods: Consecutive dyspeptic patients with infection were prospectively enrolled.